These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4242438)

  • 1. [Influence of beta-receptor blocking agents on urinary sodium excretion in man].
    Rahn KH; Johnson CE; McNay JL
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):296-7. PubMed ID: 4242438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the influence of beta-receptor blocking agents on different circulatory parameters. I. Experimental results before, during and after loading].
    Kirchhoff HW; Kuemmerle HP; von Düsterlho J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):229-45. PubMed ID: 4391093
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies on the influence of beta-receptor blockaders on different circulatory parameters. II. Results of examination in the standing position].
    Kirchhoff HW; Kuemmerle HP; von Düsterlho J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):300-14. PubMed ID: 4391818
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease.
    Epstein SE; Braunwald E
    Ann Intern Med; 1966 Jul; 65(1):20-7. PubMed ID: 5936664
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative blocking effectiveness of propranolol and of practalol [4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide] on isoprenaline in beta-1 receptor mediated calorigenesis.
    Arnold A; McAuliff JP
    J Pharm Pharmacol; 1969 Sep; 21(9):624-5. PubMed ID: 4390346
    [No Abstract]   [Full Text] [Related]  

  • 6. A nerve-blocking action of MJ-1999.
    Bartlet AL; Hassan T
    Br J Pharmacol; 1969 May; 36(1):176P-177P. PubMed ID: 5813957
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
    Fukuda M; Yamanaka T; Mizuno M; Motokawa M; Shirasawa Y; Miyagi S; Nishio T; Yoshida A; Kimura G
    J Hypertens; 2008 Mar; 26(3):583-8. PubMed ID: 18300871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treadmill investigations into the action of beta receptor antagonists on blood pressure and pulse rate.
    Kirchhoff HW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):141-4. PubMed ID: 4395479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of adrenergic beta receptor blocking with propranolol on the electrocardiographic changes caused by pitressin].
    Romeo F; Squadrito G; Nicita-Mauro V
    Atti Soc Ital Cardiol; 1968; 2():77-81. PubMed ID: 5743877
    [No Abstract]   [Full Text] [Related]  

  • 11. The peripheral vascular effects of beta adrenergic blocking agents in man.
    Mahon WA
    Angiologica; 1966; 3(5):304-17. PubMed ID: 5957697
    [No Abstract]   [Full Text] [Related]  

  • 12. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adrenergetic beta-receptor-blocking agents].
    Burckhardt D; Meier M
    Praxis; 1969 Sep; 58(36):1121-3. PubMed ID: 5820385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies with beta-receptor blocking agents and quinidine].
    Saameli K
    Helv Physiol Pharmacol Acta; 1967; 25(4):CR432+. PubMed ID: 5586888
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of catecholamine beta-receptor blocking agents on striated muscle.
    Wislicki L
    Br J Pharmacol; 1969 May; 36(1):174P-175P. PubMed ID: 5768090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the substrate provision and the coronary blood circulation of the human heart under the influence of beta-receptor-blocking agents].
    Rudolph W; Meister W; Kriener J
    Wien Med Wochenschr; 1968 Sep; 118(37):727-30. PubMed ID: 5726710
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-receptor-blocking agents and their current clinical significance].
    Deptalla H; Wiegershausen B
    Dtsch Gesundheitsw; 1968 Dec; 23(50):2353-63. PubMed ID: 4389656
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacodynamic activity spectrum of beta-receptor blocking agents].
    Kraupp O
    Wien Med Wochenschr; 1968 Sep; 118(36):696-9. PubMed ID: 4386482
    [No Abstract]   [Full Text] [Related]  

  • 19. Combinations of alpha and beta adrenergic blockers in isolated guinea-pig atria.
    Krell RD; Patil PN
    J Pharmacol Exp Ther; 1969 Dec; 170(2):262-71. PubMed ID: 4391006
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of beta-adrenergic blocking agents on the electrocardiogram of normal subjects].
    Bacuzzi E; Barbaresi F; Starcich R
    G Clin Med; 1966 Jul; 47(7):606-23. PubMed ID: 5981890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.